Background High blood glucose concentration may increase risk of death and poor outcome
after acute myocardial infarction. We did a systematic review and metaanalysis to assess the …

Despite numerous advances in treatments for cardiovascular disease, heart failure (HF)
remains the leading cause of death worldwide. A significant factor contributing to the …

Covering everything from historical and international perspectives to basic science and
current clinical practice, Miller's Anesthesia, 9th Edition, remains the preeminent reference in …

The functions of the heart are achieved through coordination of different cardiac cell
subtypes (eg, ventricular, atrial, conduction-tissue cardiomyocytes). Human pluripotent stem …

Cardiac tissue engineering is an emerging field. The suitability of engineered heart tissue
(EHT) for both in vitro and in vivo applications will depend on the degree of syncytoid tissue …

Objectives: This study was designed to assess the prognostic significance of hyperglycemia
in acute myocardial infarction (AMI) in the thrombolytic era using contemporary criteria for …

Background—Ischemia-induced cardiomyopathy usually is accompanied by elevated left
ventricular end-diastolic pressure, which follows from increased myocardial stiffness …

Cardiac tissue engineering aims at providing contractile heart muscle constructs for
replacement therapy in vivo. At present, most cardiac tissue engineering attempts utilize …

Cardiac muscle cells are equipped with specialized biochemical machineries for the rapid
generation of force and movement central to the work generated by the heart. During each …

Antiadrenergic treatment is currently an emerging and very promising approach to the
treatment of chronic heart failure. Although the adrenergic nervous system can be …